Image For Activity Cover
The Lead Episode 76: A Discussion of Asundexian versus Apixaban in Patients with Atrial Fibrillation
Description
Join moderator Melissa Middeldorp as she discusses the NEJM article Asundexian versus Apixaban in Patients with Atrial Fibrillation with Christopher C Cheung, MD, MPH and Prashanthan Sanders, MBBS, PhD, FHRS at HRS2024 in Atalnta. Brought to you live from the HRSTV Studio, this episode comes with bonus video footage.
Learning Objectives
  • Compare the use of Asundexian in patients with atrial fibrillation to the use of Apixaban in patients with atrial fibrillation.
Article Authors and Podcast Contributors
Article Authors

Jonathan P. Piccini, M.D., M.H.S., Manesh R. Patel, M.D., Jan Steffel, M.D., Keith Ferdinand, M.D., Isabelle C. Van Gelder, M.D., Ph.D., Andrea M. Russo, M.D., Chang-Sheng Ma, M.D., Shaun G. Goodman, M.D., Jonas Oldgren, M.D., Ph.D., Christopher Hammett, M.B., Ch.B., M.D., Renato D. Lopes, M.D., Ph.D., Masaharu Akao, M.D., Ph.D., Raffaele De Caterina, M.D., Ph.D., Paulus Kirchhof, M.D., Diana A. Gorog, M.D., Ph.D., Martin Hemels, M.D., Michiel Rienstra, M.D., W. Schuyler Jones, M.D., Josephine Harrington, M.D. Gregory Y.H. Lip, M.D., Stephen J. Ellis, Ph.D., Frank W. Rockhold, Ph.D., Christoph Neumann, Ph.D., John H. Alexander, M.D., M.H.S., Thomas Viethen, M.D., M.H.B.A., James Hung, M.D., Rosa Coppolecchia, D.O., M.P.H., Hardi Mundl, M.D., and Valeria Caso, M.D., Ph.D., for the OCEANIC-AF Steering Committee and Investigators​ 

Podcast Contributors

Melissa E. Middeldorp, MPH, PhD, University Medical Centre Groningen & University of Adelaide
Christopher C Cheung, MD, MPH, Sunnybrook Health Sciences Centre, University of Toronto
Prashanthan Sanders, MBBS, PhD, FHRS, University of Adelaide

Disclosure Policy

ACE Disclosure Policy

The Heart Rhythm Society is committed to the provision of Accredited Continuing Education (formerly known as Continuing Medical Education (CME)) that is balanced, objective, and evidence based. HRS adheres to the Standards for Integrity and Independence in Accredited Continuing Education of the Accreditation Council for Continuing Medical Education (ACCME) which require that those individuals in a position to control the content of an educational activity (including, but not limited to, planners, faculty, authors, committee members, content reviewers, editors, and staff) disclose all financial relationships with an ACCME-defined ineligible company* within the 24 months prior to the disclosure.

 

Any individual who refuses to disclose financial relationships is disqualified from participating in HRS ACE-certified activities. Owners and employees of ACCME-defined ineligible companies may have no role in the planning or implementation of ACE activities without a special written exemption from the HRS Chief Learning Officer that will be granted only in specific circumstances that meet ACCME requirements.


ACCME Definition:

*An ineligible company is one whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Examples of such organizations include:

  • Advertising, marketing, or communication firms whose clients are ineligible companies
  • Bio-medical startups that have begun a governmental regulatory approval process
  • Compounding pharmacies that manufacture proprietary compounds
  • Device manufacturers or distributors
  • Diagnostic labs that sell proprietary products
  • Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
  • Manufacturers of health-related wearable products
  • Pharmaceutical companies or distributors
  • Pharmacy benefit managers
  • Reagent manufacturers or sellers

 

All relevant financial relationships have been mitigated.

Host Disclosure(s):

M. Middeldorp: Nothing to disclose.

Contributor Disclosure(s):
C. Cheung: Nothing to disclose.
P. Sanders:
Membership on Advisory Committees: Boston Scientific, Medtronic PLC, Pacemate, CathRx, Research: Abbott, Becton Dickinson, Boston Scientific, CathRx, Medtronic, Pacemate.

Staff Disclosure(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):
S. Sailor: No relevant financial relationships with ineligible companies to disclose.
S. Colbert: No relevant financial relationships with ineligible companies to disclose.
Summary
Availability: On-Demand
Cost: FREE
Credit Offered:
No Credit Offered
Recommended
  Heart Rhythm Society
1325 G Street NW, Suite 500
Washington, DC 20005
P: 202-464-3400 F: 202-464-3401
E: questions@heartrhythm365.org
© Heart Rhythm Society
Privacy Policy | Cookie Declaration | Linking Policy | Patient Education Disclaimer | State Nonprofit Disclosures | FAQ
 
Android App Download IOS App Download Powered By